ACE and Hyperglycemia: Interestingly, C66 administration does not affect angiotensinogen and renin expression, but significantly reduced ACE mRNA levels (P < 0.001, Fig. 2E), indicating that the reduction in Ang II level by C66 may result from its inhibition of hyperglycaemia-induced ACE overexpression.